These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25178886)

  • 1. Moyamoya syndrome in sickle cell anaemia: a cause of recurrent stroke.
    Soares D; Bullock R; Ali S
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25178886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events.
    Dobson SR; Holden KR; Nietert PJ; Cure JK; Laver JH; Disco D; Abboud MR
    Blood; 2002 May; 99(9):3144-50. PubMed ID: 11964276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
    Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
    J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
    Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
    J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ivy Sign Predicts Ischemic Stroke Recurrence in Adult Moyamoya Patients without Revascularization Surgery.
    Nam KW; Cho WS; Kwon HM; Kim JE; Lee YS; Park SW; Rhim JH; Son YJ
    Cerebrovasc Dis; 2019; 47(5-6):223-230. PubMed ID: 31212276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ivy Sign on Fluid Attenuated Inversion Recovery Images Related to Single-Photon Emission Computed Tomography Cerebral Blood Flow in Moyamoya Disease: A Case Report.
    Matano F; Murai Y; Kubota A; Mizunari T; Kobayashi S; Morita A
    Turk Neurosurg; 2019; 29(4):598-602. PubMed ID: 28191623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke in a young boy with β-thalassemia intermedia secondary to moyamoya syndrome.
    Oberoi S; Bansal D; Singh P; Marwaha RK
    J Pediatr Hematol Oncol; 2010 Oct; 32(7):568-70. PubMed ID: 20724947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke after adenotonsillectomy in patients with undiagnosed moyamoya syndrome.
    Ahn AK; Honeybrook A; Jordan LC; Singer RJ; Tylor DA
    JAMA Otolaryngol Head Neck Surg; 2014 Nov; 140(11):1061-4. PubMed ID: 25257069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ivy sign in mildly symptomatic β-thalassemia intermedia, with development of moyamoya disease.
    El Beltagi AH; El-Sheikh A; El-Saif R; Norbash A
    Neuroradiol J; 2014 Feb; 27(1):23-8. PubMed ID: 24571831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral Revascularization for Moyamoya Syndrome Associated with Sickle Cell Disease: A Systematic Review of the Literature on the Role of Extracranial-Intracranial Bypass in Treating Neurologic Manifestations of Pediatric Patients with Sickle Cell Disease.
    Terrell D; Savardekar AR; Whipple SG; Dossani RH; Spetzler RF; Sun H
    World Neurosurg; 2020 May; 137():62-70. PubMed ID: 32014541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure.
    Fryer RH; Anderson RC; Chiriboga CA; Feldstein NA
    Pediatr Neurol; 2003 Aug; 29(2):124-30. PubMed ID: 14580655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-onset stroke with moyamoya-like syndrome and extraneurological signs: a first reported paediatric series.
    Law-Ye B; Saliou G; Toulgoat F; Tardieu M; Deiva K; Adamsbaum C; Husson B
    Eur Radiol; 2016 Aug; 26(8):2853-62. PubMed ID: 26615553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encephaloduroateriosynangiosis (EDAS) in the management of Moyamoya syndrome in children with sickle cell disease.
    Alamri A; Hever P; Cheserem J; Gradil C; Bassi S; Tolias CM
    Br J Neurosurg; 2019 Apr; 33(2):161-164. PubMed ID: 28616936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomoyamoya in sickle cell anemia.
    Garza-Mercado R
    Surg Neurol; 1982 Dec; 18(6):425-31. PubMed ID: 7163962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sickle cell cerebrovascular disease: usual and unusual findings on MR imaging and MR angiography.
    Moritani T; Numaguchi Y; Lemer NB; Rozans MK; Robinson AE; Hiwatashi A; Westesson PL
    Clin Imaging; 2004; 28(3):173-86. PubMed ID: 15158221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct Clinical and Radiographic Phenotypes in Pediatric Patients With Moyamoya.
    Kaseka ML; Slim M; Muthusami P; Dirks PB; Westmacott R; Kassner A; Bhathal I; Williams S; Shroff M; Logan W; Moharir M; MacGregor DL; Pulcine E; deVeber GA; Dlamini N
    Pediatr Neurol; 2021 Jul; 120():18-26. PubMed ID: 33962345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.
    Noguchi T; Kawashima M; Nishihara M; Hirai T; Matsushima T; Irie H
    Eur J Radiol; 2013 Dec; 82(12):e840-7. PubMed ID: 24055185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The "Ivy-Sign" in Moyamoya Disease-From MRI Pattern to Diagnosis.
    Gburek-Augustat J; Sorge I; Merkenschlager A
    Neuropediatrics; 2020 Aug; 51(4):241-244. PubMed ID: 32232811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two Sides of a Coin: Case Report of Unilateral Synangiosis and Contralateral Stroke Highlighting Consequences of Disease Progression and Efficacy of Revascularization in Sickle Cell Disease-Associated Moyamoya Syndrome.
    Slingerland AL; Karsten MB; Smith ER; Sobota AE; See AP
    Acta Haematol; 2022; 145(4):458-464. PubMed ID: 34879377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.
    Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES
    J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.